Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine

BACKGROUND: The reactogenicity of BNT162b2 COVID-19 vaccine has been commonly reported and antipyretic medications are often used for mitigating adverse reactions. Possible associations between the reactogenicity events and specific antibody responses have not been fully investigated, nor has the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tani, Naoki, Chong, Yong, Kurata, Yasuo, Gondo, Kei, Oishi, Ryo, Goto, Takeyuki, Minami, Junya, Onozawa, Kyoko, Nagano, Sukehisa, Shimono, Nobuyuki, Ikematsu, Hideyuki, Kuwano, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842119/
https://www.ncbi.nlm.nih.gov/pubmed/35177298
http://dx.doi.org/10.1016/j.vaccine.2022.02.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842119/
https://www.ncbi.nlm.nih.gov/pubmed/35177298
http://dx.doi.org/10.1016/j.vaccine.2022.02.025

Ejemplares similares